Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease

BACKGROUND: Despite substantial research and development investment in Alzheimer’s disease (AD), effective therapeutics remain elusive. Significant emerging evidence has linked cholesterol, β-amyloid and AD, and several studies have shown a reduced risk for AD and dementia in populations treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Geifman, Nophar, Brinton, Roberta Diaz, Kennedy, Richard E., Schneider, Lon S., Butte, Atul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316146/
https://www.ncbi.nlm.nih.gov/pubmed/28212683
http://dx.doi.org/10.1186/s13195-017-0237-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316146/
https://www.ncbi.nlm.nih.gov/pubmed/28212683
http://dx.doi.org/10.1186/s13195-017-0237-y

Ejemplares similares